Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Short Interest Up 21.3% in February
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 110,900 shares, a growth of 21.3% from the January 31st total of 91,400 shares. Based on an average daily volume of 78,800 […]
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 110,900 shares, a growth of 21.3% from the January 31st total of 91,400 shares. Based on an average daily volume of 78,800 […]
